![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
HER2-positive breast cancer: What is it? - Mayo Clinic
2024年4月9日 · HER2-positive breast cancer is a breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2). This protein promotes the growth of cancer cells. In about 1 of every 5 breast cancers, the cancer cells have extra copies of the gene that makes the HER2 protein.
Breast cancer types: What your type means - Mayo Clinic
2024年10月31日 · HER2 positive. Breast cancer cells that make a lot of extra HER2 protein are called HER2 positive. Targeted therapy treatments with medicine that hurts cells making too much HER2 can help control this kind of breast cancer. HER2 low. Breast cancer is called HER2 low if some of the cancer cells show signs of making extra HER2.
Cáncer de mama positivo para HER2: ¿qué es? - Mayo Clinic
2024年4月9日 · Estos tratamientos son tan efectivos que el pronóstico para cáncer HER2-positivo con HER2 es realmente bastante bueno. Algunos medicamentos estándar de quimioterapia pueden ser efectivos para tratar el cáncer de mama positivo al HER2 aunque estos medicamentos no se dirijan específicamente a la proteína HER2.
Vaccine study for HER2-positive breast cancer moves forward
We have good drugs, like trastuzumab, that can interfere with the recurrence of HER2-positive breast cancer. Our hope is that a vaccine that engages multiple aspects of the body's own immune system will build on those successes." Related. Keith L. Knutson, Ph.D. Breast cancer; HER2-positive breast cancer: What is it? Trastuzumab (Intravenous Route)
سرطان الثدي الإيجابي HER2: ما هو؟ - Mayo Clinic (مايو كلينك)
سرطان الثدي إيجابي البروتين her2 هو سرطان ثدي يعطي تشخيصُه نتيجة إيجابية لبروتين يسمى "مُستقبِل عامل نمو البشرة 2 لدى البشر"، و her2 هي اختصار لهذا الاسم. يحفز هذا البروتين نمو الخلايا السرطانية.
Trastuzumab (intravenous route) - Mayo Clinic
Trastuzumab injection is also used in combination with cisplatin and capecitabine or 5-fluorouracil to treat HER2-overexpressing metastatic (cancer that has spread) stomach and gastroesophageal (stomach and esophagus) cancer. Trastuzumab prevents the growth of some tumors that produce extra amounts of a certain substance known as the HER2 protein.
HER2 阳性乳腺癌:这是什么病? - 妙佑医疗国际
2024年4月9日 · 某些标准化疗药物也可以有效治疗 her2 阳性乳腺癌,尽管这些药物并不专门靶向 her2 蛋白。 专家建议对每例浸润性乳腺癌进行 her2 检测,因为检测结果会显著影响治疗建议和决策。her2 检测通常不作为导管原位癌的常规检测手段,除非作为临床试验的试验内容。
Ductal carcinoma in situ (DCIS) - Diagnosis and treatment - Mayo …
2024年7月19日 · Hormone therapy, also called endocrine therapy, uses medicines to block certain hormones in the body. It's a treatment for breast cancers that are sensitive to the hormones estrogen and progesterone. Healthcare professionals call these cancers estrogen receptor positive and progesterone receptor positive.
Chemotherapy for breast cancer - Mayo Clinic
2025年1月10日 · HER2-positive breast cancer; Triple-negative breast cancer; High-grade breast cancers; Cancers that have spread to the lymph nodes; Larger breast cancers; Chemotherapy as the primary treatment for advanced breast cancer. If breast cancer has spread to other parts of your body and surgery isn't an option, chemotherapy can be used as the primary ...
Tucatinib (oral route) - Mayo Clinic
2025年2月1日 · Tucatinib is also used in combination with trastuzumab to treat RAS wild-type HER2 positive colorectal cancer (cancer of the colon or rectum) that has spread throughout the body (metastatic) or cannot be removed by surgery (advanced). Your doctor will use a special test to look for these mutations.